5-Chloro-2,3-Diphenylpyrazine
41270-66-0Clc1cnc(-c2ccccc2)c(-c2ccccc2)n1VUGNCPVAXWZTOL-UHFFFAOYSA-N41270-66-0DTXSID40394713CHEMBL5426150안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
Danger
H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]
P203, P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P363, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 4 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
용도2-Chloro-5,6-diphenylpyrazine is a diphenylpyrazine derivative used in a study to determine a novel class of prostacyclin receptor agonists.
용도5-chloro-2,3-diphenylpyrazine is an intermediate of Selexipag, a medication used to treat pulmonary arterial hypertension (PAH).